Stevens Capital Management’s Prestige Consumer Healthcare PBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
Sell
-8,162
Closed -$244K 794
2019
Q1
$244K Sell
8,162
-38,629
-83% -$1.11M 0.01% 603
2018
Q4
$1.45M Buy
+46,791
New +$1.71M 0.07% 314
2018
Q3
Sell
-11,345
Closed -$435K 899
2018
Q2
$435K Buy
+11,345
New +$382K 0.02% 564
2017
Q2
Sell
-42,717
Closed -$2.37M 1013
2017
Q1
$2.37M Buy
42,717
+29,176
+215% +$1.61M 0.09% 286
2016
Q4
$705K Buy
+13,541
New +$654K 0.03% 499
2016
Q3
Sell
-5,157
Closed -$286K 1081
2016
Q2
$286K Buy
+5,157
New +$284K 0.01% 693
2014
Q3
Sell
-7,837
Closed -$266K 1192
2014
Q2
$266K Buy
+7,837
New +$251K 0.01% 846
2013
Q4
Sell
-19,420
Closed -$585K 1186
2013
Q3
$585K Buy
+19,420
New +$635K 0.02% 605

Other funds holding PBH

Stevens Capital Management's PBH Position: Q2 2019 in Review

Stevens Capital Management sold out of Prestige Consumer Healthcare (PBH) in Q2 2019, closing a stake of 8,162 shares — an estimated $244K sold.

Stevens Capital Management first reported a position in PBH in Q3 2013 and held it in 8 quarters. The position peaked at $2.37M in Q1 2017. 212 funds tracked by Wall St. Rank hold PBH as of Q2 2019.

  • Stevens Capital Management reported no remaining Prestige Consumer Healthcare position as of Q2 2019 after selling out during the quarter.
  • Stevens Capital Management sold 8,162 Prestige Consumer Healthcare shares in Q2 2019, an estimated $244K.
  • Stevens Capital Management first reported a position in Prestige Consumer Healthcare in Q3 2013 and held it in 8 quarters.
  • Stevens Capital Management's Prestige Consumer Healthcare position peaked at $2.37M in Q1 2017.
  • 212 funds tracked by Wall St. Rank held Prestige Consumer Healthcare as of Q2 2019.

Based on Stevens Capital Management's 13F filing for Q2 2019, filed 31 Jul 2019.